Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›NCCIH Natural Product Early Phase Clinical Trial Award…

U.S. National Institutes of Health·United States of America

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Closes 11/13/2026$1.1MGrants Notice
Get bids like this by emailBid source

Description

This opportunity is for investigator-initiated, early phase, clinical trials of natural products, including botanicals, dietary supplements, and probiotics. The goal is to determine whether the natural product has a strong scientific premise to justify further clinical testing. The trials must be designed to provide information of high scientific utility and support decisions about further development or testing of the natural product. Key aspects of the job include: • Replicating the impact of the natural product on target engagement when used by humans • Assessing the association between the degree of impact on target engagement and functional or clinical outcomes in a patient population • Determining how to optimize the impact of the natural product on target engagement through examination of different doses or formulations • Combining the natural product with another treatment approach that is known to engage the same target • Studying the impact of the natural product in a target population that is more responsive.

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
2/1/2024
Closes
11/13/2026
Duration
3 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-25-270

Budget estimate

$1,050,000

The Award Ceiling is explicitly stated on the source site.

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 92%

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Closes 11/13/2026Opened 2/1/2024

U.S. National Institutes of Health·United States of America

92% match

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

Closes 11/13/2026Opened 2/1/2024

U.S. National Institutes of Health·United States of America

81% match

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

Closes 11/17/2026Opened 12/20/2023

U.S. National Institutes of Health·United States of America

81% match

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

Closes 11/17/2026Opened 12/20/2023

U.S. National Institutes of Health·United States of America

81% match

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

Closes 7/30/2027Opened 9/29/2026

U.S. National Institutes of Health·United States of America

79% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

78% match

A Holistic Approach to Study Non-Addictive Natural Products for Pain Management

Closes 5/24/2027Opened 4/22/2026

U.S. National Institutes of Health·United States of America

78% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Institutes of Health·United States of America

78% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

78% match

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

Closes 2/3/2027Opened 4/1/2024

U.S. National Institutes of Health·United States of America

78% match

Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)

Closes 11/16/2029Opened 7/8/2025

U.S. National Institutes of Health·United States of America

77% match

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Closes 1/15/2027Opened 9/18/2024

U.S. National Institutes of Health·United States of America

77% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

77% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

77% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

77% match

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029Opened 9/10/2025

U.S. National Institutes of Health·United States of America

77% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. National Institutes of Health·United States of America

77% match

NIH Pragmatic Trials Conducted in Health Care Systems

Closes 2/22/2027Opened 4/29/2026

U.S. National Institutes of Health·United States of America

77% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

77% match

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. National Institutes of Health·United States of America

77% match

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

Closes 6/2/2027Opened 6/17/2024

U.S. National Institutes of Health·United States of America

77% match

NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)

Closes 3/9/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

77% match

Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

Closes 6/2/2027Opened 6/17/2024

U.S. National Institutes of Health·United States of America

76% match

NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

Closes 11/16/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

76% match

NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)

Closes 11/1/2026Opened 5/6/2026